Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
Objectives: The aim of this study was to characterize the reimbursement policy for orphan drugs (ODs) in Central and Eastern European (CEE) countries in relation to the availability and impact of clinical evidence, health technology assessment (HTA) procedure, selected economic indicators, and the d...
Saved in:
Main Authors: | Szczepan Jakubowski (Author), Pawel Kawalec (Author), Przemyslaw Holko (Author), Iwona Kowalska-Bobko (Author), Maria Kamusheva (Author), Guenka Petrova (Author), Pero Draganić (Author), Leos Fuksa (Author), Agnes Männik (Author), Fanni Ispán (Author), Vitalis Briedis (Author), Ioana Bianchi (Author), Marian Sorin Paveliu (Author), Tomas Tesar (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
by: Krzysztof Piotr Malinowski, et al.
Published: (2019) -
Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
by: Paweł Kawalec, et al.
Published: (2017) -
Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries
by: Szczepan Jakubowski, et al.
Published: (2024) -
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
by: Maria Kamusheva, et al.
Published: (2018) -
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review
by: Paweł Kawalec, et al.
Published: (2017)